Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects

Clinical trial NCT06037577 · COMPLETED

Trial details

NCT number: NCT06037577
Sponsor: ChemomAb Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis (NASH)Primary Sclerosing Cholangitis (PSC)Systemic Sclerosis (SSc)

Start date: 2019-03-05
Primary completion: 2019-05-05
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.